Pasithea Therapeutics Corp. (KTTA)

NASDAQ: KTTA · IEX Real-Time Price · USD

7.24

+0.24 (3.43%)

At close: Apr 25, 2024, 12:00 AM

6.85

-0.39 (-5.39%)

After-hours: Apr 26, 2024, 4:00 PM EDT

Pasithea Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Cash & Equivalents	16.33	33.09	52.97	0.24
Cash & Cash Equivalents	16.33	33.09	52.97	0.24
Cash Growth	-50.64%	-37.53%	21638.85%	-
Other Current Assets	0.36	0.99	0.33	0
Total Current Assets	16.69	34.08	53.3	0.25
Property, Plant & Equipment	0.22	0.63	0.02	0
Goodwill and Intangibles	9.2	9.83	0	0
Other Long-Term Assets	0	0.64	0	0
Total Long-Term Assets	9.42	11.1	0.02	0
Total Assets	26.12	45.18	53.32	0.25
Accounts Payable	2.55	1.48	0.45	0.01
Current Debt	0.08	0.16	0	0
Other Current Liabilities	0	0.24	0	0
Total Current Liabilities	2.63	1.88	0.45	0.01
Long-Term Debt	0	0.34	0	0
Other Long-Term Liabilities	0.08	0.46	1.45	0
Total Long-Term Liabilities	0.08	0.8	1.45	0
Total Liabilities	2.72	2.68	1.9	0.01
Total Debt	0.08	0.5	0	0
Debt Growth	-83.81%	-	-	-
Retained Earnings	-35.32	-19.36	-2.21	-0.04
Comprehensive Income	-0	-0	-0.01	0
Shareholders' Equity	23.4	42.5	51.42	0.24
Net Cash / Debt	16.25	32.58	52.97	0.24
Net Cash / Debt Growth	-50.13%	-38.48%	21638.85%	-
Net Cash Per Share	13.25	25.81	101.81	0.66
Working Capital	14.06	32.2	52.85	0.24
Book Value Per Share	19.08	33.67	98.84	0.66

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).